Sphera Funds Management Ltd. Bellus Health Inc. Transaction History

Sphera Funds Management Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$7.14 - $8.53 $2.21 Million - $2.64 Million	310,000 Added 63.28%	799,860 $5.76 Million
Q4 2022 Feb 14, 2023	BUY	$8.22 - $10.76 $205,500 - $269,000	25,000 Added 5.38%	489,860 $4.03 Million
Q3 2022 Nov 14, 2022	BUY	$8.95 - $12.0 $4.16 Million - $5.58 Million	464,860 New	464,860 $4.91 Million
Q3 2020 Nov 12, 2020	SELL	$2.14 - $12.02 $209,302 - $1.18 Million	-97,805 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$8.88 - $11.15 $868,508 - $1.09 Million	97,805 New	97,805 $1.01 Million

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.